The latest in CPG & Ops: 🧴 New brands & products ⚙️ Manufacturing 🍫 M&A
Culver City, CA
Joined December 2024
- Tweets177
- Following98
- Followers18
- Likes24
809,220 square feet. Freehill broke ground Nov. 3 on a northwest Houston build-to-suit for Power Electronics, which makes solar inverters and EV chargers. Phase I is due Q3 2027. How many inverter lines would you fit in a building that size?
ALT Houston card: 809,220 sq ft, Power Electronics, Phase I Q3 2027
Sponsors building captive clinical plants pull early work off the open CDMO board. Pfizer is putting $650M into a 220,000 sq ft Manufacturing Technology Center on its Groton, Conn. campus for trial APIs and drug product. Construction starts Q2 2027; ops eyed mid-2031.
A Philly viral-vector GMP site is for sale. VintaBio's 22,500 sq ft campus (three suites, fill-finish, about $17M invested) is taking bids through Dec. 15 after an Oct. 27 assignment for the benefit of creditors.
pharmamanufacturing.com/indu…
Samsung Biologics is close to closing its $1.8B buy of Swiss CDMO PolyPeptide Group after tenders for about 98% of shares. The deal adds peptide and GLP-1 manufacturing across six plants in Europe, India, and the U.S. Settlement eyed late 2026 or early 2027.
ALT Deal card: Samsung Biologics $1.8B PolyPeptide buy, ~98% shares tendered, 6 plants including U.S.
The NY Fed's Global Supply Chain Pressure Index eased to 1.26 in October from a revised 1.36 in September. Anything above zero means more stress than the long-run average, so freight and lead-time buffers still matter on the floor.
ALT Line chart of NY Fed GSCPI falling from 1.36 in September to 1.26 in October
ADP says private manufacturers cut 1,000 jobs in October while total private payrolls rose 86,000. Construction added 13,000. Factory hiring stayed flat while the rest of the private sector kept adding people.
ALT October card: manufacturing minus 1,000 jobs, construction plus 13,000, all private plus 86,000, per ADP
PharmAla signed Corealis Pharma, a CDMO in Laval, Québec, for GMP clinical supply of ALA-002 capsules. Formulation R&D is underway, and the first GMP batch comes after development.
ALT GMP Capsules card: Corealis Pharma, Laval Quebec, ALA-002 clinical supply
Pyramid Pharma Services, a Costa Mesa CDMO, moved a longtime sterile-injectable customer onto a cartridge program. It is the shop's 13th commercial product, and it follows new Groninger fill-finish and Mikron device assembly equipment.
ALT 13th card: Pyramid Pharma Services, 13th commercial product, cartridge fill-finish, Costa Mesa
